Rishab Gupta

Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin

Fang Liz Zhou, Fen Ye, Paulos Berhanu et al. · Diabetes Obesity and Metabolism · 2017 · 74 citations · Full text

Medicine, Endocrinology, Pharmacoeconomics +17

Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study

Sean D. Sullivan, Timothy S. Bailey, Ronan Roussel et al. · Diabetes Obesity and Metabolism · 2018 · 74 citations · Full text

Medicine, Endocrinology, Pharmacology +17

MicroRNA Biomarkers in Cerebrospinal Fluid and Serum Reflect Injury Severity in Human Acute Traumatic Spinal Cord Injury

Seth Tigchelaar, Rishab Gupta, Casey P. Shannon et al. · Journal of Neurotrauma · 2019 · 62 citations

Life Sciences, Biomedical Sciences, Neuroscience +14

Effect of a Community Health Worker-Based Approach to Integrated Cardiovascular Risk Factor Control in India: A Cluster Randomized Controlled Trial

Aditya Khetan, Melissa D. Zullo, Anitha Rani et al. · Global Heart · 2019 · 59 citations · Full text

Medicine, Community Health, Preventive Medicine +15

Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3)

Timothy S. Bailey, Jasmanda Wu, Fang Liz Zhou et al. · Diabetes Obesity and Metabolism · 2019 · 35 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +17